AI summary · may contain errors
In adults with difficult-to-treat ICD-10 depression and hs-CRP ≥0.3 mg/dL, tocilizumab showed no significant day-14 improvement in somatic symptoms (adjusted difference -0.12; 95% CI -2.51 to 2.28).
- Open access
- 17 cites
